Clinical Trial led by EMBARC Reveals Potential of Novel Antibody Therapy against Pseudomonas in Patients with Bronchiectasis – Results from the GREAT-2 Study
Clinical Trial led by EMBARC Reveals Potential of Novel Antibody Therapy against Pseudomonas in Patients with Bronchiectasis – Results of the GREAT-2 Study Research Highlights Proof of concept study achieves …